SCHRODINGER INC

SDGR Healthcare
$11.58
Market Cap $854.89M
P/E Ratio
Forward P/E -8.39
Dividend Yield
Beta 1.62
52W Range $11.07 - $26.69
# Hedge Funds 1
Sector Healthcare
Industry Health Information Services

Hedge Fund Ownership

1 funds holding this stock
Investor 1 % of Portfolio i Weight of this stock in the investor's portfolio Value i Total dollar value of the position Shares i Number of shares held Activity i Portfolio change type: New, Increased, Decreased, or Sold
Bill & Melinda Gates Foundation Trust Gates Foundation Trust 0.35% $124.83M 6,981,664

Insider Trading

24 transactions in the last 6 months
Insider i Name of the company insider who made the trade 24 Type i Purchase (buy) or Sale (sell) Shares i Number of shares traded Price i Price per share at time of transaction Value i Total dollar value of the transaction Trade Date i Date the transaction was executed Filing Date i Date the SEC filing was submitted
Herman JennyCAOSale608$12.84$7.81K06 Mar 202606 Mar 2026
Jenny HermanCAOSale608$12.84$7.81K06 Mar 202606 Mar 2026
Akinsanya KarenSee RemarksSale1,366$12.90$17.63K05 Mar 202606 Mar 2026
Farid RamyPresident & CEOSale3,661$12.91$47.25K05 Mar 202606 Mar 2026
Tran YvonneEVP, CLO & CPOSale1,094$12.90$14.11K05 Mar 202606 Mar 2026
Lorton Kenneth PatrickEVP, CTO & COO, SoftwareSale1,222$12.90$15.76K05 Mar 202606 Mar 2026
Jain RachitEVP & CFOSale1,631$12.90$21.03K05 Mar 202606 Mar 2026
Herman JennyCAOSale775$12.85$9.96K05 Mar 202606 Mar 2026
Yvonne TranEVP, CLO & CPOSale1,094$12.90$14.11K05 Mar 202606 Mar 2026
Jenny HermanCAOSale775$12.85$9.96K05 Mar 202606 Mar 2026
Kenneth Patrick LortonEVP, CTO & COO, SoftwareSale1,222$12.90$15.76K05 Mar 202606 Mar 2026
Ramy FaridPresident & CEOSale3,661$12.91$47.25K05 Mar 202606 Mar 2026
Rachit JainEVP & CFOSale1,631$12.90$21.03K05 Mar 202606 Mar 2026
Karen AkinsanyaPresident, Head of Therapeutics R&D and Chief Strategy Officer, PartnershipsSale1,366$12.90$17.63K05 Mar 202606 Mar 2026
Abel Robert LorneSee RemarksSale1,300$12.81$16.65K04 Mar 202606 Mar 2026
Robert Lorne AbelEVP, Chief Scientific Officer, PlatformSale1,300$12.81$16.65K04 Mar 202606 Mar 2026
Farid RamyPresident & CEOSale5,560$11.90$66.15K02 Mar 202603 Mar 2026
Akinsanya KarenSee RemarksSale2,206$11.99$26.45K02 Mar 202603 Mar 2026
Tran YvonneEVP, CLO & CPOSale776$13.80$10.71K10 Feb 202612 Feb 2026
Herman JennyCAOSale752$13.79$10.37K10 Feb 202612 Feb 2026
Lorton Kenneth PatrickEVP, CTO & COO, SoftwareSale925$13.73$12.70K10 Feb 202612 Feb 2026
Abel Robert LorneSee RemarksSale1,230$13.51$16.62K09 Feb 202611 Feb 2026
Dugan MargaretChief Medical OfficerSale1,395$21.07$29.39K16 Oct 202517 Oct 2025
Margaret DuganChief Medical OfficerSale1,395$21.07$29.39K16 Oct 202517 Oct 2025

Frequently Asked Questions

What is SDGR stock price today?

SCHRODINGER INC (SDGR) is currently trading at $11.58. The stock has a 52-week range of $11.07 to $26.69 and a market capitalization of $854.89M.

Is SDGR a good stock to buy in 2026?

SCHRODINGER INC has a P/E ratio of N/A (forward P/E: N/A), a dividend yield of none, and 1-year performance of -38.6%. 1 hedge funds hold this stock. Review the fundamentals and ownership data above to make an informed decision.

Are insiders buying or selling SDGR stock?

There have been 24 insider transactions for SDGR in recent months. Insider buys can signal management confidence, while sales may reflect diversification or personal financial planning. Check the Insider Trading section above for details.

How has SDGR stock performed over the past year?

SCHRODINGER INC (SDGR) has returned -38.6% over the past 12 months. The stock traded between $11.07 and $26.69 during this period, and is currently at $11.58.

Which hedge funds own SDGR (SCHRODINGER INC)?

1 tracked hedge funds currently hold SDGR in their portfolios as of the latest 13F filings. See the ownership table above for the complete list.

What is SDGR's market cap and valuation?

SCHRODINGER INC (SDGR) has a market capitalization of $854.89M. The trailing P/E ratio is N/A and forward P/E is N/A. The stock is classified in the Healthcare sector.

What is SDGR's revenue and profitability?

SCHRODINGER INC reported revenue of $255.87M with net income of N/A and a profit margin of N/A. The stock has a beta of 1.62.

What sector is SDGR in and who are its biggest institutional holders?

SCHRODINGER INC (SDGR) operates in the Healthcare sector. It is held by 1 tracked hedge funds. See the ownership table above for the complete list.